Onderneming Innate Immunotherapeutics Ltd Australian S.E.
Aandelen
AU000000IIL6
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Focal Adhesion Kinase
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -63,46% |
Verkoop per regio
AUD in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -63,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 31-05-00 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 25-09-23 |
Rhiannon Jones
COO | Chief Operating Officer | - | 01-02-21 |
Charlotte Mulder
PRN | Corporate Officer/Principal | - | - |
Mark Devlin
PRN | Corporate Officer/Principal | - | - |
Andrew Cooke
SEC | Corporate Secretary | 62 | 11-10-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 11-10-13 |
Robert Peach
BRD | Director/Board Member | 68 | 02-09-15 |
Warwick Tong
CHM | Chairman | - | 04-05-18 |
Founder | - | 31-05-00 | |
Jane Bell
BRD | Director/Board Member | - | 12-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 271 608 953 | 222 004 662 ( 81,74 %) | 0 | 81,74 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |